News
Watch
Journals
Conferences
Events
Resources
CE
About AJMC
Subscribe

Spotlight -

Free In-Person Regional Events Focused on Oncology and Population Health

Dennis P. Scanlon, PhD

Articles by Dennis P. Scanlon, PhD

Approaches to Improving Healthcare Delivery by Multi-stakeholder Alliances

ByMegan C. McHugh, PhD,Jillian B. Harvey, MPH,Dasha Aseyev, BS,Jeffrey A. Alexander, PhD,Jeff Beich, PhD,Dennis P. Scanlon, PhD

September 22nd 2012

The Aligning Forces for Quality Initiative: Background and Evolution From 2005 to 2012

ByDennis P. Scanlon, PhD,Jeff Beich, PhD,Jeffrey A. Alexander, PhD,Jon B. Christianson, PhD,Romana Hasnain-Wynia, PhD,Megan C. McHugh, PhD,Jessica N. Mittler, PhD

September 22nd 2012

Midterm Observations and Recommendations From the Evaluation of the AF4Q Initiative

ByJeffrey A. Alexander, PhD,Dennis P. Scanlon, PhD,Megan C. McHugh, PhD,Jon B. Christianson, PhD,Jessica N. Mittler, PhD,Romana Hasnain-Wynia, PhD,Jeff Beich, PhD

September 22nd 2012

Producing Public Reports of Physician Quality at the Community Level: The Aligning Forces for Quality Initiative Experience

ByJon B. Christianson, PhD,Karen M. Volmar, JD, MPH,Bethany W. Shaw, MHA,Dennis P. Scanlon, PhD

September 22nd 2012

Evaluating a Community-Based Program to Improve Healthcare Quality: Research Design for the Aligning Forces for Quality Initiative

ByDennis P. Scanlon, PhD,Jeffrey A. Alexander, PhD,Jeff Beich, PhD,Jon B. Christianson, PhD,Romana Hasnain-Wynia, PhD,Megan C. McHugh, PhD,Jessica N. Mittler, PhD,Yunfeng Shi, PhD,Laura J. B

September 22nd 2012

Using Websites to Engage Consumers in Managing Their Health and Healthcare

ByJessica N. Mittler, PhD,Karen M. Volmar, JD, MPH,Bethany W. Shaw, MHA,Jon B. Christianson, PhD,Dennis P. Scanlon, PhD

September 22nd 2012

Trending on AJMC

FDA Panel Backs 6 Peptides for Compounding

Teclistamab-Talquetamab Combo Cuts Myeloma Progression Risk by 89%

Oncology Leaders Call for Greater Collaboration to Advance Precision Medicine, Innovative Cancer Care

FAQs: Cyclospora Recovery, Treatment, and Outbreak Prevention Strategies

Study Shows Potential for Low-Dose CAR T, With Implications for Increased Access